16TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD)

The Clinical Trials on Alzheimer’s Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.

The 16th annual CTAD conference will be held in Boston on October 24 – 27, 2023.  

CTAD is the only event dedicated entirely to Alzheimer’s disease therapeutic trials.
Join experts from academia and industry presenting their data on Alzheimer’s disease diagnosis and therapy.

The call for abstract is closed.

Scientific program

The scientific program is available here.

Registration CTAD23

You can register for virtual attendance to benefit from the cutting-edge scientific program. Please note that due to limited space in the ballroom during the most attended presentations, there will be a live feed in another meeting room to accommodate participants registered for in-person attendance.

Register online by clicking here.